MetLife stock (NYSE: MET) currently trades around $50 per share, around 30% below (more than 44% upside) its level of approximately $72 on April 20, 2022 (pre-inflation shock high), and has the potential for sizable gains. Notably, the pre-inflation shock high is slightly below MetLife’s valuation estimate of $75 per share, which also suggests that the stock is undervalued. 2022 Inflation Shock Timeline of Inflation Shock So Far: 2020 – early 2021: Increase in money supply to cushion the impact of lockdowns led to high demand for goods; producers unable to match up.